ADAR1 Capital Management’s NextCure NXTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.62M Buy
+722,419
New +$4.02M 0.15% 129
2025
Q3
– Sell
-9,834
Closed -$54.3K – 249
2025
Q2
$54.3K Sell
9,834
-167
-2% -$896 0.01% 189
2025
Q1
$57.6K Hold
10,001
– – 0.01% 177
2024
Q4
$92.5K Hold
10,001
– – 0.02% 182
2024
Q3
$164K Buy
10,001
+2,583
+35% +$47.5K 0.03% 170
2024
Q2
$142K Buy
7,418
+3,833
+107% +$74.5K 0.03% 157
2024
Q1
$95.9K Sell
3,585
-1,450
-29% -$25K 0.02% 153
2023
Q4
$68.9K Hold
5,035
– – 0.02% 104

Other funds holding NXTC

ADAR1 Capital Management's NXTC Position: Q3 2026 in Review

ADAR1 Capital Management opened a new position in NextCure (NXTC) in Q3 2026: 722,419 shares worth $3.62M. The stake represents 0.15% of the portfolio and ranks #129 among its holdings. This is a return to the name: ADAR1 Capital Management previously reported a position in NXTC as recently as Q2 2025.

ADAR1 Capital Management first reported a position in NXTC in Q4 2023 and has held it in 8 quarters since. 33 funds tracked by Wall St. Rank hold NXTC as of Q3 2026.

  • ADAR1 Capital Management held 722,419 shares of NextCure worth $3.62M as of Q3 2026.
  • NextCure was a new ADAR1 Capital Management position in Q3 2026.
  • NextCure made up 0.15% of ADAR1 Capital Management's portfolio in Q3 2026, its #129 holding.
  • ADAR1 Capital Management first reported a position in NextCure in Q4 2023 and has held it in 8 quarters since.
  • 33 funds tracked by Wall St. Rank held NextCure as of Q3 2026.

Based on ADAR1 Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.